DNOW vs GSK · P/E 20, rev $2.49B vs P/E 13, $103.31B cap
Now Inc (DNOW) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Now Inc (DNOW) is a industrial distribution company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported DNOW revenue for 2026-06-30 was $2.49B. Net income was -$65.0M. DNOW currently screens at market cap $1.59B and trailing P/E 20.1.
GSK does not have a complete income-statement cache yet.
DNOW currently screens at market cap $1.59B and trailing P/E 20.1. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the DNOW and GSK stock pages for the full models.
Not investment advice.